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Abstract
Introduction: The aims of the present study were to identify histopathological parameters which are linked to
local clinical skin disease at two distinct anatomical sites in systemic sclerosis (SSc) patients with skin involvement
(limited cutaneous systemic sclerosis (lcSSc) or diffuse cutaneous systemic sclerosis (dcSSc)) and to determine the
sensitivity of SSc specific histological alterations, focusing on SSc patients without clinical skin involvement (limited
SSc (lSSc)).
Methods: Histopathological alterations were systematically scored in skin biopsies of 53 consecutive SSc patients
(dorsal forearm and upper inner arm) and 18 controls (upper inner arm). Clinical skin involvement was evaluated
using the modified Rodnan skin score. In patients with lcSSc or dcSSc, associations of histopathological parameters
with local clinical skin involvement were determined by generalised estimation equation modelling.
Results: The hyalinised collagen score, the myofibroblast score, the mean epidermal thickness, the mononuclear
cellular infiltration and the frequency of focal exocytosis differed significantly between biopsies with and without
local clinical skin involvement. Except for mononuclear cellular infiltration, all of the continuous parameters
correlated with the local clinical skin score at the dorsal forearm. Parakeratosis, myofibroblasts and intima
proliferation were present in a minority of the SSc biopsies, but not in controls. No differences were found
between lSSc and controls.
Conclusions: Several histopathological parameters are linked to local clinical skin disease. SSc-specific histological
alterations have a low diagnostic sensitivity.
Introduction
Systemic sclerosis (SSc) is a chronic autoimmune disease
which can affect the skin and various internal organs
[1]. One of the hallmark clinical features of SSc is skin
thickening caused by oedema and excessive accumula-
tion of collagen-rich extracellular matrix. Apart from
sclerosis, the pathogenesis of SSc is characterized by
vasculopathy, which is evidenced by nailfold capillary
abnormalities and Raynaud’s phenomenon, as well as by
the presence of antinuclear antibodies such as anticen-
tromere, anti-topoisomerase I and anti-RNA polymerase
III antibodies. The most extensively validated technique
to quantify skin involvement is the modified Rodnan
skin score (mRSS) [2]. In this scoring system, 17 body
areas are examined by clinical palpation and scored on
the basis of judgement of skin thickness on a 4-point
ordinal scale. Because the extent of skin disease corre-
lates with the disease course, patients are grouped into
disease subsets on the basis of skin involvement. The
currently most widely applied classification differentiates
three subsets, namely, limited SSc (lSSc), limited cuta-
neous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc) [3].
Patients with lcSSc have skin involvement confined to
the fingers, hands, forearms, lower legs or the face,
whereas patients with dcSSc also have more proximal
skin thickening. The group classified as lSSc has Ray-
naud’s phenomenon with nailfold capillaroscopic
abnormalities and/or SSc-associated autoantibodies, but
no clinical skin involvement. This subset is considered
to have ‘early’ SSc, as a longitudinal follow-up study has
demonstrated that these patients are at risk for progres-
sion to definite SSc [4].
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The histopathology of SSc skin has recently regained
interest because it may be integrated as an outcome
measure in clinical trials on skin disease, whereby skin
biopsies are obtained before and after administration of
a therapeutic drug [5,6]. In this way, the hyalinised col-
lagen score and the myofibroblast score have previously
been correlated with local skin score and durometry
score in patients with dcSSc [7]. Consequently, these
parameters could potentially be used to study the effect
of a drug on skin disease. Other alterations in skin his-
tology, however, have not been linked to clinical assess-
ment. In addition, studies on the skin histopathology of
SSc patients have mainly focused on alterations in
patients with established disease, leaving open the ques-
tion whether patients with ‘early’ disease have SSc speci-
fic histological alterations.
The aims of this study were (1) to identify histopatho-
logical parameters which are linked with local clinical
skin disease at two different anatomical sites in SSc
patients with skin involvement (lcSSc or dcSSc) and (2)
to determine the sensitivity of SSc-specific histological
alterations, with a focus on SSc patients with lSSc.
Materials and methods
Patients
Skin biopsies from the dorsal forearm (at the transition
of the distal one-third and the proximal two-thirds) and
the mid-upper inner arm were obtained from 53 conse-
cutive SSc patients visiting the Scleroderma Clinic of
the Ghent University Hospital. From two patients, only
one biopsy was available for analysis. All patients ful-
filled the criteria for early SSc set forth by LeRoy and
Medsger [3]. Video nailfold capillaroscopy and antinuc-
lear antibody identification were performed as described
previously [8]. Patients were assigned to the lSSc, lcSSc
or dcSSc group according to the criteria published by
LeRoy et al. [9]. Skin involvement was clinically assessed
according to the 17-site mRSS, whereby local skin invol-
vement is determined for each site, including the dorsal
forearm, on a semiquantitative scale (0 = normal thick-
ness, 1 = mild thickening, 2 = moderate thickening and
3 = severe thickening) [10]. A normal reference set was
included in the analysis. This set contained the skin
biopsies from the inner upper arm of patients who were
referred for a lupus band test and in whom further eva-
luation excluded any specified autoimmune disease. This
study was conducted after approval of the Ghent Uni-
versity Hospital Ethical Committee was obtained and all
patients had signed informed consent.
Full-thickness skin biopsies (approximately 1.5 cm long
and 0.5 cm wide) were surgically obtained while the
patients were under local anaesthesia. Biopsy samples
were stored in formaldehyde and embedded in paraffin.
Sections of 5 μm were cut and stained with haematoxylin
and eosin, Masson trichrome and colloidal iron accord-
ing to standard techniques. Paraffin-embedded sections
were also used for immunohistochemistry.
Immunohistochemistry
Paraffin-embedded sections were dewaxed and heated in
antigen retrieval buffer at 98°C for 20 minutes using citrate
buffer (pH 6) or Tris buffer (pH 9) (Pascal: Dako,
Glostrup, Denmark). After rinsing and blocking endogen-
ous peroxidase, sections were incubated for 60 minutes
with the following mouse monoclonal antibodies (mAbs):
CD3 (T cells; Novocastra, Newcastle, UK) and a-smooth
muscle actin (a-SMA) (myofibroblasts, clone 1A4; Dako).
Parallel sections were incubated with irrelevant isotype-
matched mAbs as negative controls. The sections were
subsequently incubated for 15 minutes with a biotinylated
antimouse secondary antibody, followed by 15-minute
incubation with a streptavidin-peroxidase complex
(LSAB+ Kit; Dako). The colour reaction was developed
using 3-amino-9-ethylcarbazole substrate (Dako) as chro-
mogen. Finally, the sections were counterstained with hae-
matoxylin. All incubations were carried out at room
temperature, and the sections were washed with phos-
phate-buffered saline between all steps.
Selection of scoring parameters for SSc histological skin
alterations
Studies of SSc skin histopathology have described altera-
tions in different skin compartments, including atrophy
and increased pigmentation of the epidermis [11], loss
of the epidermal papillae [11], increase of melanophages
(’pigment incontinence’) [11], the presence of a mono-
nuclear perivascular infiltrate and myofibroblasts
[7,12-14], sclerosis [7], narrowing of arteriolar lumina in
the deep vascular plexus (reticular dermis) [15] and dis-
appearance and entrapment of dermal adnexae and cal-
cification [11,12]. To this set of alterations, we added
two key histopathological features of other scleroderma-
like disorders, namely, mucin deposition and fibroplasia
[16,17]. Because analysis of routine biopsies revealed the
presence of telangiectasia, focal exocytosis (that is, the
presence of lymphocytes in the epidermis) and parakera-
tosis in some SSc biopsies, these items were also added
to the set of scoring parameters [18]. Scoring systems
for different parameters were obtained from previous
publications as much as possible. An overview of the
skin parameters that were scored is shown in Table 1.
The hyalinised collagen score and the myofibroblast
score were assessed on a 10-cm Visual Analogue Scale [5].
The epidermal thickness was scored using a semiquantita-
tive scale on the basis of the mean number of keratinocyte
layers (stratum basale and stratum spinosum) in a zone
between two rete ridges (that is, undulations of the der-
moepidermal junction) in five microscopic fields chosen at
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random (0 = mean less than three layers, 1 = mean of
three or four layers, 2 = mean of five or six layers, 3 =
mean of more than six layers), a scoring system which has
also been used for the synovial lining layer [14,19]. Mono-
nuclear cellular infiltration was scored on a semiquantita-
tive scale as 0 (few scattered cells), 1 (maximum number
of cells per collection at least 10), 2 (maximum number of
cells per collection between 10 and 50) or 3 (maximum
number of cells per collection at least 50) [14]. Mucin
deposition in the reticular dermis was evaluated by scoring
the degree of acid mucopolysaccharide staining on a semi-
quantitative scale as negative, very slight, slight, fair or
abundant [16]. Entrapment of an eccrine sweat gland was
defined as the absence of any surrounding fat tissue (Fig-
ure 1A). Focal exocytosis was defined as the presence of
T-lymphocytes in the epidermis at least at two distinct
sites (Figure 1B). Intima proliferation in deep arterioles
was considered pathologic if the vessel wall thickness
exceeded the diameter of the vessel lumen (Figure 1C).
Parakeratosis was defined as the presence of nuclei in the
stratum corneum (Figure 1D). Pigment incontinence
was defined as the presence of melanin in papillary
macrophages at least at two distinct sites (Figure 1E). Tel-
angiectasia was defined as enlarged papillary capillaries
(Figure 1F).
Stained slides were coded so that a blinded analysis
could be performed. Slides from the dorsal forearm were
analysed by two independent observers (MH and JTVP)
who were uninformed of any clinical data. All scoring
parameters were judged to be reliable, as the interobser-
ver agreement was substantial ( > 0.6 for all categorical
parameters and intraclass correlation coefficient >0.7 for
all continuous parameters). For continuous parameters,
the mean of the two observers was used for analysis. In
case of a discrepant score for a categorical parameter, a
consensus was determined by the two observers. Slides
from the upper inner arm were scored twice by one
observer (JTVP). For continuous parameters, the mean of
the two scores was used for analysis. In case of a discre-
pant score for a categorical parameter, a consensus was
determined by a third evaluation. Because fibroplasia and
calcification were not observed in a single biopsy, these
items were left out of all analyses.
Statistical analysis
In patients with lcSSc or dcSSc, associations of histo-
pathological parameters with local clinical skin involve-
ment were determined by generalised estimation
equation (GEE) modelling with a correction for subject
level and biopsy site. Local skin involvement at the dorsal
forearm was defined as a local clinical score of at least 1.
Since the upper inner arm local skin score is not included
in the mRSS, all patients with dcSSc were considered to
have local skin involvement at this site. In case a signifi-
cant interaction between biopsy site and local clinical
skin involvement was found in the GEE model, statistical
testing for the effect of skin involvement was separately
performed for the dorsal forearm and the upper inner
arm. For normally distributed parameters, the Pearson
correlation coefficient was used to determine the correla-
tion with the dorsal forearm score. Otherwise, the Spear-
man correlation coefficient was used. For categorical
parameters, Fisher’s exact test was used to analyse the
association with the dorsal forearm score. Mann-Whitney
U test (continuous data) and Fisher’s exact test (categori-
cal data) were used to compare lSSc biopsies with normal
controls. P ≤ 0.05 was considered statistically significant.
All analyses were performed using PASW 18.0 software
(SPSS, Inc., Chicago, IL, USA).
Results
Clinical characteristics of the patients
Skin biopsies from the dorsal forearm and the upper inner
arm were obtained from 53 consecutive SSc patients
Table 1 Overview of the skin histology parameters and
scoring systema
Method Parameter Scoring system
Histology
(H&E)
Epidermal pigmentation 10-cm VAS
Histology
(MT)
Hyalinised collagen 10-cm VAS [7]
IHC (a-SMA) Myofibroblasts 10-cm VAS [7]
Histology
(H&E)
Mean epidermal thickness Semiquantitative
Histology
(H&E)
Mononuclear cellular infiltration Semiquantitative
[14]
Histology (CI) Mucin deposition in deep dermis Semiquantitative
[16]
Histology
(H&E)
Calcification Present or absent
Histology
(MT)
Entrapment of an eccrine sweat
gland
Present or absent
Histology
(H&E)
Fibroplasia Present or absent
IHC (CD3) Focal exocytosis Present or absent
Histology
(H&E)
Loss of adnexae Present or absent
Histology
(H&E)
Loss of epidermal papillae Present or absent
Histology
(H&E)
Intima proliferation of deep
arterioles
Present or absent
Histology
(H&E)
Parakeratosis Present or absent
Histology
(H&E)
Pigment incontinence Present or absent
Histology
(H&E)
Telangiectasia in papillary dermis Present or absent
aa-SMA, a-smooth muscle actin; CI, colloidal iron; H&E, haematoxylin and
eosin; IHC, immunohistochemistry; MT, Masson trichrome; VAS, Visual
Analogue Scale.
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(17 males and 36 females; mean age ± SD, 52 ± 12 years).
Seven SSc patients (13%) had no clinical skin involvement
(lSSc), and 46 SSc patients (87%) had skin involvement (29
lcSSc and 17 dcSSc patients). Twenty-five patients used
methotrexate, and 11 patients used low-dose corticoster-
oids (< 15 mg prednisolone/day). Table 2 summarizes the
features of the different SSc patient subsets. Normal skin
samples taken from the upper inner arm were included as
a reference set (n = 18 comprising 7 males and 11 females;
mean age ± SD, 44 ± 17 years).
Associations of local clinical skin involvement and
histological alterations
To examine associations of local skin disease with histolo-
gical parameters, we analysed the biopsies from patients
with lcSSc or dcSSc (n = 46). We found that, independently
of the anatomical site of the biopsy, the hyalinised collagen
score, the myofibroblast score, the mean epidermal thick-
ness, the mononuclear cellular infiltration and the fre-
quency of focal exocytosis differed significantly between
biopsies with and without local skin involvement (a = 0.05;
GEE) (Table 3). For the continuous parameters, only the
epidermal thickness (r = 0.553; P < 0.001), the myofibro-
blast score (r = 0.507; P < 0.001) and the hyalinised col-
lagen score (r = 0.572; P < 0.001) correlated with the local
clinical skin score. No association was found between the
local clinical score and the frequency of focal exocytosis (P
= 0.06).
Sensitivity and specificity of histological alterations
To determine the specificity of the studied histological
parameters, we analysed 18 upper inner arm biopsies
DA
EB
C DF
Figure 1 Histopathological alterations in the skin of SSc patients. All photographs were taken at ×200 magnification. (A) Entrapment of an
eccrine sweat gland. (B) Focal exocytosis (arrow). (C) Intima proliferation in a deep arteriole. (D) Parakeratosis (arrow). (E) Pigment incontinence
(arrow). (F) Telangiectasia. (A and C-F) Haematoxylin and eosin staining. (B) Anti-CD3 staining.
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from patients who were referred for a lupus band test
and in whom further evaluation excluded any specified
autoimmune disease. Myofibroblasts, intima prolifera-
tion of deep arterioles and parakeratosis were not seen
in these biopsies (Table 4). Comparison with the biop-
sies of the patients with lSSc (n = 7) revealed no
statistically significant differences (Table 4). Analysis of
all SSc biopsies showed that myofibroblasts, intima pro-
liferation of deep arterioles and parakeratosis were pre-
sent in, respectively, 22%, 19% and 5.8% of the dorsal
forearm biopsies and in 14%, 14% and 0% of the upper
inner arm biopsies.
Table 2 Clinical data of patients with lSSc, lcSSc and dcSSca
Subset lSSc (n = 7) lcSSc (n = 29) dcSSc (n = 17)
Mean age, yr (± SD) 51 ± 16 51 ± 13 55 ± 8,0
Female/male, n 6/1 21/8 9/8
Median disease durationb (rangec) 2 (2 to 21) 6 (0 to 35) 2 (0 to 12)
Median mRSS (range) 0 (0 to 0) 4 (0 to 14) 21 (4 to 27)
Median local skin score dorsal forearm (range) 0 (0 to 0) 0 (0 to 2) 1 (0 to 3)
ACR criteria, n 0 14 17
ANA, n
Topoisomerase I 0 5 8c
Centromere 6 14 3c
RNA polymerase III 0 1 3
U1-RNP 0 3 0
aACR, American College of Rheumatology; ANA, antinuclear antibodies; dcSSc, diffuse cutaneous systemic sclerosis; lSSc, limited systemic sclerosis; lcSSc, limited
cutaneous systemic sclerosis; mRSS, modified Rodnan skin score; U1RNP, U1-ribonucleic protein; bdisease duration from first non-Raynaud’s phenomenon
symptom; cone patient had both anticentromere and anti-topoisomerase I antibodies. crange denotes the full interval between the smallest and largest values.
Table 3 Histological characteristics of patients with lcSSc or dcSSca
Dorsal forearm Upper inner arm
Histological
characteristics
No local skin
involvement
(n = 24)
Local skin
involvement
(n = 22)
No local skin
involvement
(n = 29)
Local skin
involvement
(n = 16)
P
valueb
Mean epidermal
pigmentation (± SD)
33 ± 22 37 ± 23 17 ± 18 40 ± 20 NRc
Mean hyalinised collagen
(± SD)
20 ± 21 42 ± 29 11 ± 13 43 ± 33 < 0.001
Mean myofibroblast score
(± SD)
1.1 ± 4.9 12 ± 21 0.79 ± 3.8 14 ± 27 0.004
Mean epidermal thickness
(± SD)
1.6 ± 0.58 2.3 ± 0.61 1.1 ± 0.51 1.5 ± 0.48 < 0.001
Mean mononuclear cellular
infiltration (± SD)
0.89 ± 0.34 1.1 ± 0.38 1.4 ± 0.79 1.9 ± 0.77 0.005
Mean mucin deposition in
deep dermis (± SD)
1.7 ± 1.3 2.1 ± 1.4 0.96 ± 0.83 1.5 ± 1.2 0.09
Entrapment of eccrine
sweat gland, n (%)
10 (42) 11/21 (52) 8 (28) 6/15 (40) 0.284
Focal exocytosis, n (%) 1 (4.2) 5 (23) 14 (48) 11 (69) 0.043
Loss of adnexae, n (%) 10 (42) 12 (55) 9 (31) 3/15 (20) 0.94
Loss of epidermal papillae,
n (%)
10 (42) 5 (23) 1 (3,4) 0 (0) 0.122
Intima proliferation of deep
arterioles, n (%)
3 (13) 6 (27) 5 (17) 2/15 (13) 0.596
Parakeratosis, n (%) 0 (0) 3 (14) 0 (0) 0 (0) NRd
Pigment incontinence, n
(%)
9 (38) 13 (59) 16 (55) 9 (56) 0.141
Telangiectasia in papillary
dermis, n (%)
2 (8,3) 0 (0) 0 (0) 0 (0) NRd
alcSSc, limited cutaneous systemic sclerosis; dcSSc, diffuse cutaneous systemic sclerosis; SD, standard deviation; NR, not reported; b generalised estimation
equation (GEE) modelling was used to determine the effect of local skin involvement for each variable, correcting for subject level and biopsy site; cin the GEE
model, the effect of this parameter differed significantly between the skin sites (Student’s t-test was used to evaluate the upper inner arm, P < 0.001, and the
dorsal forearm, P = 0.580); dstatistical testing could not be performed.
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Discussion
Because of the rarity of the disease, few studies have sys-
temically addressed the skin histopathology of SSc. Pre-
vious studies may have been hampered by bias due to
the inclusion of only dcSSc patients [7], by failure to
perform biopsies at the same anatomical site in all
patients [15] or by failure to include a normal control
group or to link alterations to clinical scoring [11,13].
The present study was designed to overcome these
issues and to identify histopathological alterations in the
skin of SSc patients which are linked to clinical skin
scoring or might have diagnostic relevance.
The results of this study show that independent of the
biopsy site (dorsal forearm or inner upper arm), the hya-
linised collagen score, the myofibroblast score and the
mean epidermal thickness are associated with the pre-
sence of local clinical skin involvement. Furthermore,
these three parameters correlated well with the local
clinical skin score at the dorsal forearm. In agreement
with our data, Kissin et al. [7] reported a good correla-
tion of the hyalinised collagen score and the myofibro-
blast score with clinical scoring in patients with dcSSc.
The link between histopathological alterations and clini-
cal assessment at two independent skin sites in a large
set of SSc biopsies, including patients from different dis-
ease subsets and with early and late disease, suggests
these parameters might be potential candidates as out-
come measures in clinical trials on skin disease. How-
ever, longitudinal studies should address their sensitivity
to change before they can be considered validated mea-
sures [20]. Given that the link with clinical scoring was
independent of the skin site, our data indicate that in
patients with dcSSc, biopsies from the upper inner arm
may be used to study histological parameters.
One interesting finding of our study is the link between
clinical skin scoring and epidermal changes. Apart from
the increased mean epidermal thickness in biopsies with
local clinical skin involvement, we also found parakerato-
sis in a minority of clinically involved skin biopsies from
the dorsal forearm, which points to a disturbance of epi-
dermal differentiation [21]. Consistent with these results,
Aden et al. [22] demonstrated that the epidermis in
involved SSc skin shows thickening and altered differen-
tiation, mimicking an active wound-healing phenotype.
In contrast, older literature reported atrophy of the epi-
dermis in SSc skin biopsies [11]. Also, we found that
local clinical skin involvement was associated with a
higher epidermal pigmentation at the upper inner arm
but not at the dorsal forearm, which is probably related
to the different sun exposure of the two biopsy sites.
A second research aim of this study was to determine
the sensitivity of SSc-specific histological alterations,
focusing on SSc patients without clinical skin involve-
ment (lSSc). These patients have Raynaud’s phenom-
enon and SSc-associated antinuclear antibodies and/or
nailfold capillaroscopic alterations without skin involve-
ment. At the upper inner arm, we found no differences
between lSSc and control biopsies. Concerning the spe-
cificity of histological parameters for SSc, we could not
detect parakeratosis, myofibroblasts or intima prolifera-
tion of the deep arterioles in controls. However, these
alterations were present in only a minority of the SSc
biopsies. Thus, SSc-specific histological alterations have
a low diagnostic sensitivity.
Table 4 Histological characteristics of patients with lSSc and controlsa
Upper inner arm
Histological characteristics lSSc
(n = 7)
Controls (n = 18) P value
Mean epidermal pigmentation (± SD) 22 ± 23 16 ± 20 0.532
Mean hyalinised collagen (± SD) 2.3 ± 2.4 2.1 ± 1.9 0.893
Myofibroblast score (± SD) 0 ± 0 0 ± 0 NRb
Mean epidermal thickness (± SD) 0.86 ± 0.48 0.92 ± 0.31 0.714
Mononuclear cellular infiltration (± SD) 1.3 ± 1.1 1.5 ± 0.8 0.650
Mucine deposition in deep dermis (± SD) 1.2 ± 0.49 1.3 ± 0.7 0.663
Entrapment of eccrine sweat gland, n (%) 3 (43) 1/13 (7.7) 0.101
Focal exocytosis, n (%) 2 (29) 5/17 (16) 1.0
Loss of adnexae, n (%) 1 (14) 7 (50) 0.174
Loss of epidermal papillae, n (%) 2 (29) 2 (11) 0.548
Intima proliferation of deep arterioles, n (%) 0 (0) 0 (0) NRb
Parakeratosis, n (%) 0 (0) 0 (0) NRb
Pigment incontinence, n (%) 1 (14) 3 (17) 1.0
Telangiectasia in papillary dermis, n (%) 1 (14) 1 (5.6) 0.490
alSSc, limited systemic sclerosis; NR, not reported; bstatistical testing could not be performed.
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Conclusions
In conclusion, the systematic analysis of skin biopsies
from 53 consecutive SSc patients and 18 normal con-
trols revealed that the mean epidermal thickness, the
hyalinised collagen score and the myofibroblast score
are linked to local clinical skin involvement and are cor-
related with the local skin score. Concerning histological
alterations in lSSc, we found no significant differences
with control skin at the upper inner arm. Finally, myofi-
broblasts, intima proliferation of the deep arterioles or
parakeratosis in a skin biopsy are useful diagnostic mar-
kers for SSc, although they have a low sensitivity.
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